A 62-year-old woman was in remission from previously treated stage IV diffuse large B-cell lymphoma with cranial involvement. She presented with new-onset hoarseness of voice and choking; MRI of the brain showed disease recurrence in the left cavernous sinus. She was subsequently referred for F-FDG PET/CT with contrast for further evaluation of lymphomatous recurrence. 18F-FDG PET/CT not only revealed hypermetabolic activity in the left cavernous sinus correlating to the MRI findings but also showed an interesting manifestation explaining the patient's hoarseness of voice, being neurolymphomatosis along the left vagus nerve. © 2012 by Lippincott Williams & Wilkins.link_to_subscribed_fulltex
Copyright © 2015 Ali Ozan Oner et al. This is an open access article distributed under the Creative ...
In a patient suffering from peripheral neuropathy due to neurolymphomatosis, fused PET-CT imaging, p...
textabstractNeurolymphomatosis (NL) is a rare clinical entity. The International Primary CNS Lymphom...
Abstract: In neurolymphomatosis, malignant lymphocytes infiltrate the pe-ripheral nervous system in ...
Abstract: In neurolymphomatosis, malignant lymphocytes infiltrate the peripheral nervous system in t...
Neurolymphomatosis is a rare manifestation of non-Hodgkin lymphoma characterized by infiltration of ...
Item does not contain fulltextNeurolymphomatosis (NL) is a rare clinical entity that is defined as i...
Objective To explore the value of FDG PET-CT in the diagnosis of neurolymphomatosis (NL). Methods ...
Neurolymphomatosis is a rare entity defined as nerve infiltration by neurotropic abnormal lymphocyte...
Fluorine-18-deoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) has been...
A 37-year-old woman was diagnosed with Stage IVB diffuse large-B cell lymphoma, presenting with bulk...
Neurolymphomatosis (NL) is the neoplastic endoneurial invasion of the peripheral nervous system. It ...
Neurolymphomatosis (NL) is a rare entity. It is usually a manifestation of B-cell lymphoma. Here we ...
To clarify the prognostic value of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/comp...
Neurolymphomatosis (NL) is a rare clinical entity. The International Primary CNS Lymphoma Collaborat...
Copyright © 2015 Ali Ozan Oner et al. This is an open access article distributed under the Creative ...
In a patient suffering from peripheral neuropathy due to neurolymphomatosis, fused PET-CT imaging, p...
textabstractNeurolymphomatosis (NL) is a rare clinical entity. The International Primary CNS Lymphom...
Abstract: In neurolymphomatosis, malignant lymphocytes infiltrate the pe-ripheral nervous system in ...
Abstract: In neurolymphomatosis, malignant lymphocytes infiltrate the peripheral nervous system in t...
Neurolymphomatosis is a rare manifestation of non-Hodgkin lymphoma characterized by infiltration of ...
Item does not contain fulltextNeurolymphomatosis (NL) is a rare clinical entity that is defined as i...
Objective To explore the value of FDG PET-CT in the diagnosis of neurolymphomatosis (NL). Methods ...
Neurolymphomatosis is a rare entity defined as nerve infiltration by neurotropic abnormal lymphocyte...
Fluorine-18-deoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) has been...
A 37-year-old woman was diagnosed with Stage IVB diffuse large-B cell lymphoma, presenting with bulk...
Neurolymphomatosis (NL) is the neoplastic endoneurial invasion of the peripheral nervous system. It ...
Neurolymphomatosis (NL) is a rare entity. It is usually a manifestation of B-cell lymphoma. Here we ...
To clarify the prognostic value of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/comp...
Neurolymphomatosis (NL) is a rare clinical entity. The International Primary CNS Lymphoma Collaborat...
Copyright © 2015 Ali Ozan Oner et al. This is an open access article distributed under the Creative ...
In a patient suffering from peripheral neuropathy due to neurolymphomatosis, fused PET-CT imaging, p...
textabstractNeurolymphomatosis (NL) is a rare clinical entity. The International Primary CNS Lymphom...